"learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus

Diabetes Technology and Therapeutics

Volumn 19, Issue 1, 2017, Pages 41-48

  Wang, Youqing ^a   Zhang, Jinping ^b   Zeng, Fanmao ^a   Wang, Na ^b   Chen, Xiaoping ^b   Zhang, Bo ^b   Zhao, Dong ^a   Yang, Wenying ^b   Cobelli, Claudio ^c  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Alcohol; Artificial pancreas; Closed loop; Hypoglycemia; Learning type model predictive control; Type 1 diabetes

Indexed keywords

ALCOHOL; GLUCOSE; INSULIN ASPART; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CLINICAL STUDY; EXERCISE; FEMALE; GLUCOSE SENSOR; HUMAN; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MALE; OPEN STUDY; PRIORITY JOURNAL; ALGORITHM; ANALYSIS; ARTIFICIAL PANCREAS; BLOOD; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL; MIDDLE AGED; PHYSIOLOGICAL FEEDBACK; PILOT STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEEDBACK, PHYSIOLOGICAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; PILOT PROJECTS; YOUNG ADULT;

EID: 85010015330     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0328     Document Type: Article

References (26)

1. International Diabetes Federation: IDF Diabetes Atlas, 7th ed. 2015. http://diabetesatlas.org/
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993;329:977-986.
3. Nathan DM, et al.: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
4. Brown WV: Microvascular complications of diabetes mellitus: renal protection accompanies cardiovascular protection. Am J Cardiol 2008;102 (12 Suppl):10-13.
5. Kovatchev BP, et al.: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858.
6. Stei, GM, et al.: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55: 3344-3350.
7. Grant P: A new approach to diabetic control: fuzzy logic and insulin pump technology. Med Eng Phys 2007;29:824-827.
8. Atlas E, et al.: MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33: 1072-1076.
9. Miller S, et al.: Automatic learning algorithm for the MDlogic artificial pancreas system. Diabetes Technol Ther 2011;13:983-990.
10. Mauseth R, et al.: Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor. J Diabetes Sci Technol 2010;4:913-922.
11. Kovatchev B, et al.: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J. Diabetes Sci Technol 2010;4:1374-1381.
12. Patek SD, et al.: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
13. Del FS, et al.: First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care 2014; 37:1212-1215.
14. Lee JJ, et al.: In silico evaluation of an artificial pancreas combining exogenous ultrafast-acting technosphere insulin with zone model predictive control. J Diabetes Sci Technol 2013;7:215-226.
15. Haidar A, et al.: Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Lancet Diabetes Endocrinol 2015;3:17-26.
16. Haidar A, et al.: Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol 2015; 3:595-604.
17. Cobelli C, et al.: Diabetes: models, signals, and control. IEEE Rev Biomed Eng 2009;2:54-96.
18. Wang Y, et al.: Model predictive control with learning-type set-point: application to artificial pancreatic beta-cell. AIChE J 2010;56:1510-1518.
19. Wang Y, Dassau E, Doyle FJ III: Closed-loop control of artificial pancreatic beta-cell in type 1 diabetes mellitus using model predictive iterative learning control. IEEE Trans Biomed Eng 2010;57:211-219.
20. Dalla Man C, et al.: The UVA/PADOVA type 1 diabetes simulator: new features. J Diabetes Sci Technol 2014;8:26-34.
21. Clarke W, Kovatchev B: Statistical tools to analyze continuous glucose monitor data. Diabetes Technol Ther 2009;11 Suppl 1:S45-S54.
22. The Diabetes Research in Children Network Study Group: Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005;147:528-534.
23. Guelfi K, Jones T, Fournier P: The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 2005;28:1289-1294.
24. Turner B, et al.: The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes. Diabetes Care 2001;24:1888-1893.
25. Russell SJ, et al.: Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35:2148-2155.
26. Phillip M, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368:824-833.